Schaeffer's Top Stock Picks for '25

Pharma Stock Could Be Headed Towards Fresh Record Highs

MNTA is not slowing down, a historical signal says

Digital Content Manager
Sep 24, 2020 at 3:08 PM
facebook X logo linkedin


The shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) are up 0.1% to trade at $52.34 at last check, after a massive bull gap in August boosted the security to an all-time-high of $52.45 on Sept. 22. And while the equity is already enjoying an impressive 280.1% year-over-year lead, with fresh support from the 20-day moving average and a historic bull signal now flashing, more upside may be on the horizon.

Specifically, the stock's recent peak comes amid historically low implied volatility (IV), which has been a bullish combination for MNTA in the past. According to data from Schaeffer's Senior Quantitative Analyst Rocky White, there have only been two other times in the past five years when the stock was trading within 2% of a 52-week high, while its Schaeffer's Volatility Index (SVI) sat in the 20th percentile of its annual range or lower -- as is the case with the MNTA's current SVI of 18.2%, which sits slightly above the 8th percentile of its 12-month range. The data shows the security was higher a month later, averaging a return of 5.4% for that time period. From its current perch, a move of similar magnitude would put MNTA just above the $55 mark, at yet another record peak.

MNTA 2

Analysts are still skeptical of Momenta Pharmaceuticals stock, with seven of the nine in coverage carrying a tepid "hold" rating, and only the remaining two sporting a "strong buy." Meanwhile, the stock's 12-month consensus target price of $35.81 is barely a premium to its current perch. In simpler terms, there remains plenty of room for upgrades as well as price-target hikes on MNTA in the coming weeks. 

The options pits are already leaning more bullish, on the other hand. In the last 50 days, 24,455 calls have been exchanged, compared to 10,834 puts. Echoing this is MNTA's Schaeffer's put/call open interest ratio (SOIR), which stands higher than just 26% of readings from the past year. This implies short-term option traders have rarely been more call-biased.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));